1Rao CN, Reddy P, Reeder DJ, eta l. Prokaryotic expression, purification, and reconstitution of biological activities ( antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2 [J]. Biochem Biophys Res Commun, 2000, 276 (3): 1286--1294.
2Sprecher CA,Kisiel W,Mathew e S,et al. Molecular cloning, expression, and partial characterization of a second human tissue factor-pathway inhibitor [J]. Proc Natl Acad Sci USA,1994,91(8):3353--3357.
4Hube F, Reverdiau P, Iochmann S, et al. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line [J]. Thromb Res, 2003,109 (4) :207-- 215.
5Rao CN,Lakka SS, Kin Y, et al. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas [J]. Clin Cancer Res, 2001,7 : 570-- 576.
6Chand HS, Foster DC, KisielW, etal. Structure, function and biology of tissue factor pathway inhibitor-2 [J]. Thromh Haemost, 2005,94 (6): 112 -- 230.
7Peersehke EI, Petrovan R J, Ghebrehiwet B, et al. Tissue factor pathway inhibitor-2 ( TFPI-2 ) recognizes the complement and kininogen binding protein gClqR/p33 (gClqR) :implications for vascular inflammation [J]. Thromb Haemost, 2004,92 (4) : 811 --819.
8Jin M, Udagawa K, Miyagi E, et al. Expression of serine proteinase inhibitor PPS/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo [J]. Gynecol Oncol, 2001,83 (2) :325 -- 333.
5Rao CN, Reddy P, Reeder D, et al. Prokaryotic expression,purification, and reconstitution of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2 [J]. Biochem Biophys Res Commun, 2000,276(3): 1286 - 1294.
6Neaud V, Hisaka T, Monvoisin A, et al. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitar-2 on human hepatocelluar carcinoma cells [J]. J Biochem, 2000, 275:35565 - 35569.
7Jin M, Udagawa K, Miyagi E, et al. Expression of serine proteinase inhibitor PPS/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo [J]. Gynec Oncol, 2001, 83:325 - 333.
8Miyagi Y, Yasumitsu H, Eki T, et al. Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human mapping panel analysis [J]. Genomics, 1996, 35:267 -268.
9Kerr J, Leary JA, Hurse T, et al. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANHI locus [J]. Oncogene, 1996, 13:1815 - 1818.
10Lakka SS, Konduri SD, Mohanam S, et al. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 [J]. Clin Exp Metastasis, 2000,18(3): 239 -244.
5Balint EE, Vousden KH. Activation and activities of the p53 tumour suppressor protein [J]- Br J Cancer, 2001, 85 (12): 1813-1823.
6Robinson MW, Connolly B. Proteomic analysis of the excretory- secretory proteins of" the TrichineUa spiralis L1 larva, anematode parasite of skeletal muscle[J]. Proteomics, 2005, 5 (17) : 4525-4532.
7Wang L, Cui J, Hu DD, et al. Identification of early diagnostic antigens from major excretory-secretory proteins of Trichinella spira!is muscle larvae using immunoprote omics [J]. Parasit Vectors, 2014, 7: 40.
8Sasa V, Natasa I, Alisa G, et al. Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction[J]. Centr Eur J Immunol, 2015, 40(1 ) : 42-53.
9Gong P, Zhang J, Cao L, et al. Identification and characterization of myeloma-assoeiated antigens in Trichinella spiralis[J]. Exp Parasitol, 2015, 127(4) : 784-788.
10Raval GN, Bharadwaj S, Levine EA, et al. Loss of expression of tropomyosin-1, a novel class Ⅱ tumor suppressor that induces anoikis, in primary breast tumors[J]. Oncogene, 2003, 22(40): 6194-6203.
